{"id":8,"date":"2017-01-31T22:32:51","date_gmt":"2017-01-31T22:32:51","guid":{"rendered":"https:\/\/whangareiicu.com\/?page_id=8"},"modified":"2017-03-04T12:25:35","modified_gmt":"2017-03-03T23:25:35","slug":"publications","status":"publish","type":"page","link":"https:\/\/whangareiicu.com\/?page_id=8","title":{"rendered":"Research & Publications"},"content":{"rendered":"\n
Tweet<\/a><\/div>\n

RESEARCH<\/h1>\n

We are an active member of the ANZICS Clinical Trials Group. We have participated in a number of studies including RENAL, MET and LUNGSAFE for the ESICM<\/p>\n

 <\/p>\n

The RENAL Replacement Therapy Study Investigators. Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients.N Engl J Med 2009; 361:1627-1638.<\/span><\/p>\n

RENAL\u00a0Replacement Therapy study\u00a0Investigators,\u00a0Bellomo R, et al.An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial.\u00a0<\/strong>Crit Care Med. 2012 Jun;40(6):1753-60.<\/p>\n

Bellani et al.\u00a0Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. February 23, 2016, Vol 315, No. 8.<\/p>\n

Laffey et al,\u00a0LUNG SAFE Investigators and the ESICM Trials Group.\u00a0Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2016 Dec;42(12):1865-1876.<\/p>\n

Psirides A. J. , Hill J,\u00a0 Jones D.Rapid Response Team activation in New Zealand hospitals\u2014a multicentre prospective observational study. Anaesth Intensive Care 2016 | 44:3<\/p>\n

PUBLICATIONS<\/h1>\n

Manara A R, Thomas I, Harding R.A case for stopping the early withdrawal
\nof life sustaining therapies in patients with devastating brain injuries. JICS 2016:0(0)<\/p>\n

 
\nMoore L<\/span><\/span>SP<\/span><\/span>, Owens, DS, Jepson A, Turton J, Ashworth S, <\/span><\/span>Donaldson <\/span><\/span>H, <\/span><\/span>Holmes<\/span><\/span> A<\/span><\/span>.<\/span><\/span> \u2018<\/span><\/span>Waterborne <\/span>Elizabethkingia<\/span> meningoseptica<\/span> in adult critical care: an analysis of an outbreak and the organism\u2019s role as an emerging nosocomial pathogen<\/span><\/span>.<\/span><\/span>\u2019 <\/span><\/span>Emerging Infectious Diseases<\/span><\/span>. 2016:22(1)<\/span><\/span><\/p>\n

Meyer E. ‘A review of renal protection strategies’ South Afr J Anaesth Analg. 2015:21(2):5-8<\/p>\n

Jeyanathan<\/span> J & Owens D \u2018Objective Structured Clinical Examination in Intensive Care Medicine\u2019 TFM<\/span><\/span> publishing ltd.<\/span><\/span> July 2015<\/span><\/span><\/p>\n

Kalkoff M, Sleigh J, Cursons R, Bertinelli A, Jogia P, La Pine M, Richards M, Towers R, Devlin,\u00a0Alpha-1 adrenergic receptor mRNA expression in circulating leucocytes after cardiac surgery, Anaesth and Intensive CareVol 2008 36(4); p535-543<\/p>\n

Jogia P, Kalkoff M, JW Sleigh, A. Bertinelli , La Pine M, <\/em>AM Richards, G.Delvin.\u00a0NT-pro BNP secretion and clinical endpoints in cardiac surgery intensive care patients. Anaesth Int Care. 2007; 35:363-369<\/p>\n

Kalkoff\u00a0M,\u00a0Cursons\u00a0RT,\u00a0Sleigh\u00a0JW,\u00a0Jacobson\u00a0GM.The use of real time rtPCR to quantify inflammatory mediator expression in leukocytes from patients with severe sepsis. Anaesth Intensive Care. 2004 Dec; 32(6): 746-55.<\/p>\n

Ireland N, Kalkoff M, Cursons RT, Sleigh JW.\u00a0 Messenger RNA expression of multiple immune mediators in leukocytes from elective orthopaedic surgical patients.<\/em>\u00a0 Anaesth Intensive Care.\u00a0 2004: 32(2); 188-195.<\/p>\n

 <\/p>\n\n

Tweet<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

RESEARCH We are an active member of the ANZICS Clinical Trials Group. We have participated in a number of studies including RENAL, MET and LUNGSAFE for the ESICM   The RENAL Replacement Therapy Study Investigators. Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients.N Engl J Med 2009; 361:1627-1638. RENAL\u00a0Replacement Therapy study\u00a0Investigators,\u00a0Bellomo R, et al.An … Continue reading “Research & Publications”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-8","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/whangareiicu.com\/index.php?rest_route=\/wp\/v2\/pages\/8","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/whangareiicu.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/whangareiicu.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/whangareiicu.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/whangareiicu.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8"}],"version-history":[{"count":15,"href":"https:\/\/whangareiicu.com\/index.php?rest_route=\/wp\/v2\/pages\/8\/revisions"}],"predecessor-version":[{"id":197,"href":"https:\/\/whangareiicu.com\/index.php?rest_route=\/wp\/v2\/pages\/8\/revisions\/197"}],"wp:attachment":[{"href":"https:\/\/whangareiicu.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}